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Abstract
Background—Suicide is major public health concern. It is imperative to find robust biomarkers
so that at-risk individuals can be identified in a timely and reliable manner. Previous work suggests
mechanistic links between increased cytokines and risk for suicide, but questions remain regarding
the etiology of this association, as well as the roles of sex and BMI.
Methods—Analyses were conducted using a randomly-ascertained extended-pedigree sample of
1882 Mexican-American individuals (60% female, mean age=42.04, range=18-97). Genetic
correlations were calculated using a variance components approach between the cytokines TNF-α,
IL-6 and IL-8, and Lifetime Suicide Attempt and Current Suicidal Ideation. The potentially
confounding effects of sex and BMI were considered.
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Results—159 individuals endorse a Lifetime Suicide Attempt. IL-8 and IL-6 shared significant
genetic overlap with risk for suicide attempt (ρg=0.49, pFDR=7.67x10−3; ρg=0.53, pFDR=0.01), but
for IL-6 this was attenuated when BMI was included as a covariate (ρg=0.37, se=0.23,
pFDR=0.12). Suicide attempts were significantly more common in females (pFDR=0.01) and the
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genetic overlap between IL-8 and risk for suicide attempt was significant in females (ρg=0.56,
pFDR=0.01), but not in males (ρg=0.44, pFDR=0.30).
Discussion—These results demonstrate that: IL-8 shares genetic influences with risk for suicide
attempt; females drove this effect; and BMI should be considered when assessing the association
between IL-6 and suicide. This finding represents a significant advancement in knowledge by
demonstrating that cytokine alterations are not simply a secondary manifestation of suicidal
behavior, but rather, the pathophysiology of suicide attempts is, at least partly, underpinned by the
same biological mechanisms responsible for regulating inflammatory response.
Keywords
suicide; inflammation; genetics; biomarkers; mood
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Introduction
A recent report by the Centers for Disease Control and Prevention indicated that in the
United States alone suicide rates increased by more than 30% between 1999 and 20161
making suicide a leading cause of death. Moreover, this report does not account for the fact
that suicide attempts are grossly underreported, with twenty or more attempts estimated for
every completion 2,3.
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The need for biomarkers to identify suicide risk in an effective and timely manner has never
been greater. Biomarkers are objective indicators of illness risk 4 and one potential
biomarker of suicide is inflammation. There is strong evidence for altered levels of
inflammation in individuals experiencing suicidality, particularly in pro-inflammatory
cytokines TNF-α, IL-6 and IL-8 5,6. This association has been demonstrated in several
psychiatric disorders, in both the periphery and central nervous system, in individuals that
have either attempted or completed suicide, and in a plethora of centrally- and peripherallymeasured cytokines 7-23.
However, important questions remain regarding the relationship between TNF-α, IL-6 and
IL-8 and risk for lifetime suicide attempt or current suicidal ideation. First, the etiologic
origins of the relationship are unclear. Risk for suicide has been shown to be heritable 24 as
have levels of TNF-α, IL-6 25,26 and IL-8 27. However, no study has attempted to assess any
potential overlap in the genetic factors that influence inflammation and suicide risk.
Therefore, it is not known whether inflammation is directly involved in the pathophysiology
of suicidal behavior, or arises as a secondary manifestation of these behaviors.
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Second, despite consistent sex differences in both suicidal behavior and immune response,
the effect of sex is rarely examined 28. Males more often complete suicide than females
(although recent trends indicate that that gap is narrowing 29). Paradoxically, females make,
on average, twice as many suicide attempts as males. This difference in mortality rates is
thought to stem from males more often choosing violent and lethal suicide methods than
females 30. There are also sex differences in how the immune system responds to both
foreign and self-antigens 31. In general, female immune responses tend to be stronger,
resulting in greater immunity (e.g. enhanced vaccine response), but also increased
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susceptibility to inflammatory and autoimmune diseases 28,32,34. A handful of studies on
suicidal behavior have assessed the impact of sex on inflammation levels 9,35-40, but no
study, to date, has tested whether any genetic overlap between inflammation and risk for
suicidal behavior varies as a function of sex. Evidence for genetic overlap in one sex but not
the other might hint at important differences between males and females in the
pathophysiology of suicidal behavior.

Author Manuscript

Third, increased adiposity is a well-established correlate of inflammation 41, but studies on
the relationship between inflammation and suicide have generally not examined the effect of
adiposity on this relationship, or treated it as a nuisance covariate 9,11,39. In particular, IL-6
production is thought to increase with adiposity, which is typically measured using its proxy
body mass index (BMI), with up to a third of circulating IL-6 originating from adipose
tissue 42-44. Evidence for a link between suicide and BMI is mixed 45. Some studies report
an inverse association between BMI and suicide completion 46-48 and attempt 49-51, while
others report a positive association with completions 52,53 and attempts 54-56. Of the four
studies on suicidal behavior that tested the influence of BMI on inflammation, three
indicated that BMI had no significant effect 13,37,38, and one showed that BMI was
significantly associated with inflammation 57. Thus, current evidence for an association
between BMI, inflammation and suicide, is mixed.
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Previous studies have been unable to provide answers to these questions. Family-based data
(e.g. twins or extended pedigrees) are the gold standard for establishing the extent of genetic
influence (i.e. heritability) on individual traits, as well as genetic overlaps (i.e. genetic
correlation) between traits, but no study on inflammation and suicide has been conducted in
families. Moreover, a sizable sample is required for such studies and while one of the more
recent studies looking at the relationship between IL-6 and suicide had a relatively large
sample (N = 784, 9), many studies prior to that had samples of less than or just over onehundred individuals 6. These sample sizes and lack of statistical power may partly account
for why the effects of sex and BMI have been difficult to pin down.
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Using a large, multi-generational, multi-family sample of 1882 Mexican-American
individuals combined with univariate and multivariate variance components methods we
present the first study to disentangle shared genetic effects on suicidal behavior and cytokine
levels. We chose to investigate the shared genetic influences of cytokines and suicide
because of robust associations between risk for suicidal behavior and cytokine levels. In the
blood-based assay available in the sample three cytokines were present at detectable levels
for subsequent analysis to take place: IL-6, IL-8 and TNF-α. The aims of this study were
threefold, to establish: (a) the degree of genetic overlap between both lifetime suicide
attempt and current suicidal ideation and three different cytokines; (b) the extent to which
the genetic overlap between IL-6, over and above IL-8, is confounded by BMI; and (c)
whether the genetic overlap between risk for suicide and either interleukin was sex-specific.
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Methods
Participants
The sample comprised 1882 individuals from extended pedigrees (83 families, mean size =
21.67 individuals, range 2-178 individuals). The sample was 60.43% female and had a mean
age of 42.04 years (sd = 15.74 years, range = 18-97 years). Individuals in this Genetics of
Brain Structure and Function Study (GOBS) have actively participated in research for over
18 years and were randomly selected from the community. Inclusion criteria were: 1)
Mexican American ancestry, 2) part of a large family, and 3) live within the San Antonio
region (see 58 for recruitment details). All participants provided written informed consent on
forms approved by the institutional review board at the University of Texas Health Science
Center of San Antonio.
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Suicide Assessment
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Participants completed the semi-structured Mini-International Neuropsychiatric Interview
(MINI;59). Interviews were conducted by masters- and doctorate-level research staff who
had established reliability for conducting suicide risk assessment (κ≥0.85). Suicidality was
assessed in two ways in the present study, both assessments were taken from Section C of
the MINI. Lifetime Suicide Attempt was assessed by item C6: ‘Did you ever make a suicide
attempt?’. Our Lifetime Suicide Attempt index is therefore a dichotomous trait, with a score
of 1 indicating a “yes” response and 0 indicating a “no” response. The MINI also includes a
section on current suicidality (items C1-C5), asking whether in the past month the
participant thought they would be better off dead (C1); wished that they were dead (C2);
wanted to harm themselves (C3); thought about suicide (C4); or had a suicide plan (C5).
These items were collapsed to generate a categorical index of Current Suicidal Ideation, with
a score of 1 indicating that any item between C1-C5 was endorsed and a score of 0
indicating that none were endorsed. The presence of major depressive, anxiety, alcohol and
substance use disorders was also evaluated as part of the MINI assessment. Subjects who
reported possible pathology were discussed in case conference meetings with licensed
psychologists and/or psychiatrists. Consensus diagnoses for major depressive disorder and a
lifetime suicide attempt were determined using available medical records, the MINI, and the
interviewer’s narrative.
Inflammation Measurement

Author Manuscript

Participants completed a venipuncture between the hours of 7am and 11am for the
measurement of inflammation markers. Blood was drawn after a 12-hr fast. Blood samples
were centrifuged for 20 min at 4°C, aliquoted in 50uL volumes (chiclets) of EDTA plasma
and stored at −80°C within 4 h ofvenipuncture. Inflammation assays were run in plasma
using a Milliplex MAP Human Adipokine Magnetic Bead Panel 2 (Millipore catalog
#HADK2MAG-61K) on a Luminex 200 instrument. The cytokines run were TNF-α, IL-6
and IL8. Assays were performed in 96-well plates on plasma samples stored at −80°C. 10%
of the samples were run in duplicate on separate plates. Intra-assay coefficients of variation
were <10% for all markers. Minimum detectable concentration (pg/mL) was 0.2, 0.3, and
0.3 for IL-6, IL-8 and TNF-α respectively.

Brain Behav Immun. Author manuscript; available in PMC 2020 April 20.

Knowles et al.

Page 5

Quantitative Genetic Analysis

Author Manuscript

All genetic analyses were performed in SOLAR 60. SOLAR implements a maximumlikelihood variance decomposition approach to determine the proportions of phenotypic
variance that are due to genetic and environmental influences. The simplest such
decomposition (univariate polygenic analysis) is one where the additive genetic contribution
of a single trait is indexed by its narrow-sense heritability, denoted by h2. We first estimated
the heritability of all traits. All inflammation measures were normalized using an inverse
Gaussian transformation. For all traits, age, age^2, sex and their interactions, as well as BMI
were entered as covariates into univariate polygenic models.
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Under a bivariate polygenic model, the phenotypic covariance between each inflammation
phenotype and suicide attempt is decomposed into its genetic and environmental
constituents to determine the extent to which they are influenced by shared genetic effects.
Bivariate polygenic analysis was applied to pairs of inflammation and suicide traits, with
relevant covariates (those deemed significant in univariate analysis, see above) for each trait.
We also ran the bivariate polygenic models with potentially confounding diagnoses as
covariates including: any anxiety disorder, current and lifetime substance and alcohol
dependence disorders, bipolar disorder type I and type II, schizoaffective disorder and
schizophrenia.
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We also applied a coefficient-of-relatedness-analysis to lifetime suicide attempt and each
cytokine. Briefly, this analysis leverages the many coefficients of relationship that exist in
extended-pedigree data. The coefficient of relationship refers to the average number of
alleles held in common between individuals. The coefficient of relatedness refers to the
average number of alleles held in common between individuals; for example, first-degree
relatives (e.g. full siblings or parents) share on average 50% of their alleles, second-degree
relatives (e.g. grandparents or aunts/uncles) share 25%, third-degree relatives (e.g. greatgrandparents or great-aunts/-uncles) share 12.5%, and so on. Thus, it is possible, given an
individual with a disease, to index all other pedigree members by their degree of relatedness
to that individual. This scalar can then be used to perform a fixed-effect single-degree-offreedom test within the univariate polygenic analysis framework (outlined above), providing
an estimate of the standardized genetic covariance between the potential endophenotype and
illness risk 61. This analysis is useful because affected individuals are excluded and thus,
confounding by factors such as medication status and alteration in inflammation levels as a
consequence of suicide attempt is minimized.
To control for multiple testing of main effects, the false discovery rate (FDR) was set at 5%
62.
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Results
Heritability of Risk for Suicide Attempt and Suicidal Ideation
Of the individuals assessed as part of GOBS, 159 endorsed having attempted suicide in their
lifetime and 135 endorsed some level of current suicidal ideation. Of those individuals that
had attempted suicide, 98 had a diagnosis of a past major depressive disorder. Table 1
provides descriptive statistics for these individuals. A greater proportion of females than
Brain Behav Immun. Author manuscript; available in PMC 2020 April 20.
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males had attempted suicide and were experiencing current suicidal ideation, but age and
BMI were fairly consistent across groups (Table 1).
Table 2 shows results of univariate polygenic analysis, including covariate effects, on risk for
suicide attempt and current suicidal ideation. Both suicide attempt (h2 = 0.46, pFDR =
1.68x1O−4) and suicidal ideation (h2 = 0.47, pFDR = 1.15x1O−03) were significantly
heritable. Sex was a significant covariate of both suicide traits (p = 0.01 and p = 0.04,
respectively) but neither age, nor age^2 (nor their interactions with sex), nor BMI were
significant covariates of either suicide trait.
Heritability of Cytokines
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The heritability estimates and covariate effects for the interleukin markers are shown in
Table 2. TNF-α (h2 = 0.26, pFDR = 3.11x10−08), IL-6 (h2 = 0.18, pFDR = 1.68x10−04) and
IL-8 (h2 = 0.30, pFDR = 7.15x10−13) were significantly heritable (Table 2) and were
significantly associated with age. IL-8 and TNF-α were significantly associated with sex and
Il-6 and TNF-α showed strong association with BMI.
Genetic Correlation between Cytokines with Risk for Lifetime Suicide Attempt and Current
Suicidal Ideation
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The results from bivariate polygenic analysis (including significant covariates from each trait
according to univariate polygenic analysis, see above) applied to risk for lifetime suicidal
attempt and current suicidal ideation paired with each cytokine marker are shown in Table 3.
This analysis revealed that only IL-8 (ρg = 0.49, se = 0.17, pFDR = 8.94x1O−03) exhibited a
significant genetic overlap with risk for lifetime suicide attempt. The genetic correlation
between IL-8 and current suicidal ideation was not significant. Neither TNF-α nor IL-6
showed significant genetic correlation with risk for lifetime suicide attempt nor current

suicidal ideation.
Figure 1 shows results of coefficient-of-relatedness analysis, which excluded affected
individuals. While IL-8 (β = 0.54, se = 0.15, pFDR = 1.25x1O−03) levels varied as a function
of genetic risk for suicide attempt, TNF-α (β = 0.20, se = 0.15, pFDR = 0.25) and IL-6 (β =
0.12, se = 0.05, pFDR = 0.47) levels did not (Figure 1). Altogether, these results suggest that
IL-8, but not IL-6 or TNF-α, has genetic overlap with risk for suicide attempt, and also that
IL-8, but not IL-6 or TNF-α, varies with genetic risk for suicide attempt in unaffected
relatives. In sum, in this sample, IL-8 appears to be a better marker of suicide risk than IL-6.

Author Manuscript

The genetic correlations between the inflammatory markers were all significantly different
from zero but also significantly different from 1 indicating partial genetic overlap with
specificity between markers (Table S1).
Comorbid psychiatric diagnoses derived from the MINI as well as self-reported somatic
medical conditions and self-reported current prescriptions are listed in Table S2 and Table
S3. The genetic correlation between lifetime suicide attempt and IL-8 remained significant
when those comorbid conditions (any alcohol or substance use disorder, bipolar disorder,
psychosis, diabetes) that were significant covariates of either trait were included as
covariates in the bivariate polygenic model (ρg = 0.39, se = 0.19, pFDR = 0.03).
Brain Behav Immun. Author manuscript; available in PMC 2020 April 20.
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The genetic correlation between lifetime suicide attempt and IL-8 remained significant when
currently prescribed medications (antidepressants, antidiabetics, ACE inhibitor,
antipsychotics, diuretics, opioids) that were significant covariates of either trait were
included as covariates in the bivariate polygenic model (ρg = 0.48, se = 0.18, pFDR =
7.13x10−03).
The Effect of BMI on the Relationship Between Risk for Lifetime Suicide Attempt and IL-6
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Given previous findings on IL-6 and suicide risk, it was surprising that IL-8, but not IL-6,
demonstrated a significant genetic overlap with risk for lifetime suicide attempt. Since IL-6
was significantly associated with BMI, BMI (mean = 31.38, SD = 7.53, range =
15.53-78.37) was included as a covariate in the bivariate polygenic model between IL-6 and
suicide attempt. Removing BMI as a covariate generated a significant genetic correlation (ρg
= 0.53, se = 0.19, pFDR = 0.02), suggesting that the effects of BMI should be carefully
considered when investigating the relationship between inflammatory measures, particularly
IL-6, and risk for suicide attempt. We also ran a trivariate model of IL-6, lifetime suicide
attempt and BMI. Using this model we estimated the genetic correlations between pairs of
traits in the same model rather than treating BMI as a confound or nuisance covariate.
Inspection of Figure 2 shows that the genetic correlation between IL-6 and risk for lifetime
suicide attempt was not significant when BMI was included as a third phenotype in the
model.
Removing BMI as a covariate in the bivariate polygenic model between TNF-α and suicide
attempt did not alter the non-significant genetic correlation between the trait pair (ρg = 0.22,
se = 0.20, pFDR = 0.36).
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The Effect of Sex on the Relationship Between Lifetime Suicide Attempt and IL-8

Author Manuscript

Since both suicide attempt and IL-8 exhibited effects of sex (Table 2), we also ran the
bivariate polygenic model between suicide attempt and IL-8 separately in males and
females. In females, the genetic correlation between IL-8 and risk for suicide attempt was
significant (ρg = 0.56, se = 0.21, pFDR = 0.02), but not in males (ρg = 0.27, se = 0.86, pFDR =
0.36). However, the heritability of risk for suicide attempt in the bivariate model was much
lower in males (h2 = 0.11, se = 0.36) than in females (h2 = 0.52, se = 0.17). This may be
because there is an insufficient number of cases in males for h2 to be reliably estimated. To
circumvent this limitation, we constrained the threshold of risk for suicide attempt in males
to be the same as that in females (= 1.27), resulting in a heritability of risk for suicide
attempt similar to that in females (h2 = 0.55, se = 0.37). However, the genetic correlation
remained non-significant (ρg = 0.44, se = 0.41, pFDR = 0.36). These analyses suggest that the
relationship between suicide attempt and IL-8 in this sample is moderated by the sex, such
that the relationship is driven largely by females and is not evident in males. This finding
implies a strong sex-specific effect for IL-8 on lifetime risk for suicide attempt.
Does Major Depressive Disorder (MDD) Confound the Relationship Between Lifetime
Suicide Attempt and IL-8?
Of the 159 individuals that had attempted suicide, 98 (62%) also had a lifetime diagnosis of
MDD, making it possible that MDD confounded the relationship between IL-8 and lifetime
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suicide attempt. However, when the presence of any major depressive disorder was included
as a covariate in the bivariate polygenic model the relationship between IL-8 and lifetime
suicide attempt remained significant (ρg = 0.48, se = 0.20, pFDR = 0.02). Moreover, in a
trivariate model where the genetic correlations between trait pairs are estimated in the same
model, the genetic correlation between risk for suicide attempt and IL-8 remained significant
(ρg = 0.48, pFDR = 0.01), the genetic correlation between risk for suicide attempt and MDD
was also, unsurprisingly, significant (ρg = 0.92, pFDR = 3.00x10−04), and the genetic
correlation between risk for MDD and IL-8 was significant (ρg = 0.40, pFDR = 0.04). Of the
112 females that had attempted suicide, 72 (=64%) had been diagnosed with MDD. Running
the trivariate model in females alone generated similar results to those from the entire
sample. The genetic correlation between suicide attempt and IL-8 was significant (ρg = 0.52,
pFDR = 0.03), as was the genetic correlation between suicide attempt and MDD (ρg = 0.90,
pFDR = 1.92x10-03). However, the genetic correlation between IL-8 and MDD was not
significant (ρg = 0.42, pFDR = 0.07).

Discussion
There is clear evidence for inflammatory alterations in individuals who have engaged in
suicidal behavior6. Using data from a large, multi-family, multi-generational sample we have
advanced understanding of this relationship in several ways.
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First, we tested the extent to which alterations in the inflammatory markers IL-6 and IL-8
shared a genetic overlap with risk for suicide attempt. Studies have already shown that
suicide attempts are associated with increased inflammation 5,6. However, no study has
previously looked at whether this association is caused by the same genes affecting both
traits, as opposed to environmental factors (e.g. inflammation levels increasing after a
suicide attempt). We provide evidence that plasma-based IL-8 and risk for suicide attempt
are driven, at least in part, by a common set of genes. This suggests that alterations in
peripherally measured IL-8 do not arise merely as a consequence of suicidal behavior but
that some of the same genes that affect inflammation levels also mediate risk for suicide
attempt. That is, the biological mechanisms that regulate IL-8 are some of the same that
impact risk for a suicide attempt. Future studies attempting to isolate genes that influence
risk for suicide attempt might focus their attention on some of the well-characterized
molecular pathways for IL-8 regulation.

Author Manuscript

Second, we tested whether the genetic overlap between IL-8 and risk for suicide attempt
varied as a function of sex. In line with previous literature 30, both suicidal ideation and
attempts were significantly more common in women than in men in the present sample. By
stratifying our analyses by sex, we showed that a genetic correlation between IL-8 and risk
for suicide attempt was present in both males and females but that, overall, the effect
appeared to be driven by females. This finding suggests important differences in the
pathophysiology of suicide attempts in males and females. Specifically, in females, but not
necessarily in males, the biological mechanisms associated with IL-8 are a key contributor to
risk for suicide. This finding is in line with evidence that the immune response, including the
production of cytokines and chemokines, is strongly affected by sex 31, and that women are
more susceptible than men to inflammation-induced mood symptoms 63. Recent findings
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showed that depressed males exhibited no differences in a range of serum-based proinflammatory markers compared to healthy controls, while depressed females showed higher
levels on a number of markers, including IL-8 64. Our trivariate results in females showed
that risk for suicide attempt, but not MDD, had shared genetic influences with IL-8,
suggesting that suicidality, rather than other aspects of depressive symptomatology, drives
the apparent relationship between MDD and inflammation. However, the non-significant
genetic correlations between risk for suicide and MDD in females could also be due to a
lack of power, particularly given that we observed separate and significant correlations in the
larger sample. Future work might focus on what specifically drives these differences in
males and females, for example the interaction between sex hormones, immune response,
and suicidality 65,66.
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Third, we investigated the extent to which BMI, as a proxy of adiposity, confounded the
relationship between IL-6 and risk for suicide attempt. IL-6 has been described previously as
one of the most reliable peripheral biomarkers of MDD 67-69. IL-6 is more often studied,
than for example IL-8, in relation to suicidality 6. However, IL-6 is susceptible to a major
confounder, adiposity, which is also often associated with disorders of mood 70,71. Up to a
third of circulating IL-6 originates from adipose tissue 42. Indeed, in the present study, the
relationship between risk for suicide attempt and IL-6 was confounded by BMI since the
genetic correlation between IL-6 and suicide attempt was only significant when BMI was
not included as a covariate. Of course, BMI is an imperfect proxy for adiposity because it
cannot differentiate between muscle and fat 72. Nevertheless, the present study suggests that
BMI is an important source of bias in IL-6 levels and should be considered when assessing
the association between IL-6 and suicide. This is not to say that BMI should be included as a
covariate in all studies focusing on the relationship between mood and/or suicide and
inflammation, however our results strongly suggest that the possibly influence of BMI on
increased inflammation levels should be considered.
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We showed that IL-8, but not IL-6 (when BMI was included as a covariate) or TNF-α,
overlapped with risk for suicide attempt. This is intriguing since these are three belong to a
diverse group of key communicators in the development of both acute and chronic
inflammation 73, called cytokines. However, each also has distinct structural morphologies
and roles 74. IL-6 and TNF-α are members of pleiotropic cytokines with roles related to the
maturation of B cells into anti-body producing plasma cells, T cell activation, B-lymphocyte
function and haemtopoiesis 73,75,76. Chemokines (or, chemotactic cytokines) are a family of
small cytokines that include IL-8, whose primary role is to induce chemotaxis in local cells,
recruiting leukocytes to the site of infection or injury 73. Thus, the two interleukins have
quite different roles in the inflammatory response; while IL-6 is a cytokine that initiates an
inflammatory response by triggering signaling cascades, IL-8 is a chemokine that initiates
cell movement to recruit immune cells to the site of infection. To the extent that IL-6 and
IL-8 have different roles it makes sense that one, but not the other, might be involved in the
pathophysiology of risk for suicide. However, further work is required to delineate how
chemotaxis, particularly in the central nervous system, might increase risk for suicidal
behavior.
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Despite a wealth of research dedicated to the topic, few, if any, clinically translatable
biomarkers have been identified in psychiatry 77. This study provides strong support for IL-8
as a biomarker of risk for suicide attempt. Recent national increases in suicidal behavior3,
combined with the poor predictive power of traditional clinical risk factors 78, mean that the
need for robust markers of suicidal behavior has never been greater. This is particularly true
when one considers that 54% of individuals who died by suicide in 2016 had no diagnosed
mental illness 1. IL-8 is already in routine use as a marker in various medical subspecialties
for a number of clinical conditions, including prostatitis, non-Hodgkin’s lymphoma, bladder
cancer, pulmonary infections and others 79). Our findings suggest that IL-8 might also have
utility in psychiatry, particularly in the detection of suicidal intent.
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The heritability of TNF-α, IL-6 and IL-8 have been published previously. Heritability
estimates of IL-6 from twin studies range between 0.17 and 0.61, though the majority of
studies indicate estimates closer to 0.6125,26,80-83. The classical twin design has been
criticized for giving upwardly biased heritability estimates {84-86. Indeed, a large extended
pedigree study indicated that the heritability of IL-6 was 0.25, which is somewhat closer to
the heritability found in the present study 87. Moreover, one of the twin studies that
accounted for BMI in their models, as we did in the present study, showed that the
heritability of IL=6 was 0.26 26. TNF-α and IL-8 have featured less prominently in
heritability studies of inflammatory traits. The heritability of TNF-α has been estimated
between 0.26 and 0.53 25,26. Only one study has, to the best our knowledge, investigated the
heritability of IL-8 in humans prior to the present one and that estimated heritability of IL-8
to be 1.00 27. The authors of that study acknowledge that the high heritability of IL-8 might
be due to an unapparent infection running in families or possibly due to medication effects.
Pedigree-based analyses in cows and baboons indicate that the heritability of IL-8 is 0.30
and 0.28 respectively 88,89. Thus, in general the heritability of cytokines vary considerably in
the literature which is likely due to the variety of research designs and inflammation assays
employed. However, the estimates given in the present study fall within the limits of those
published previously.

Author Manuscript

The present study has a number of limitations that might be addressed by future work. First,
personality traits such as impulsivity or aggressiveness might confound or even mediate the
relationship between inflammation and suicide attempt. Impulsivity and aggression have
been cited as essential features of suicidal behavior 90,91. Moreover, impulsivity and suicide
attempt via a violent method are related to plasma-based IL-6 39. Second, the participants in
the present study are of Mexican American ancestry and it is possible that the results we
observe here are population specific. Subsequent work should focus on replicating our
results in other ethnicities. Third, increased circulating cytokine levels have been observed in
response to stress 92, infection 93, trauma 94, arthritis 95,96, psoriasis 97, atherosclerosis 98
and obesity 99. While we accounted for BMI other confounds were not accounted for, which
might have affected our heritability (and by extension genetic correlation) estimates. Fourth,
as authors of previous studies have noted common environmental influences, e.g. an
unapparent infection running in a family, might increase inflammation and confound
estimates of heritability (and by extension genetic correlations) 27, however the families in
question were nuclear families. The present study, on the other hand, used an extended
pedigree design. It is a widely held view among genetics researchers that one of the benefits
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of extended pedigrees relative to smaller families is that there is reduced confounding of
genetic and shared environmental effects because family members are usually distributed
across multiple households 100. Where in the present study the largest family comprised 178
individuals (mean size = 21.67) it is highly unlikely that entire pedigrees were subject to
such common environmental effects. Fifth, inflammation levels vary diurnally 101. While in
the present study all blood draws were completed within a narrow time window in the
morning. Future work that might focus on tracking whether inflammation levels track with
suicidal ideation, which are subject to change over a matter of hours 102,103. This would be
an advancement of the current study, which used a relatively crude index of suicide
assessment.

Author Manuscript
Author Manuscript

It is not possible, in the present study, to draw causal inference from our results due to the
cross-sectional nature of the study. Although, we found evidence for a strong and significant
genetic correlation between risk for suicide attempt and IL-8 levels. A genetic correlation, in
contrast to a phenotypic correlation, implies that both traits are influenced by partially
overlapping genetic factors: here, directionality is of course guaranteed (genes caused the
correlation between the traits). Causal evidence for the association between inflammation
and depression has been provided by experiments using exogenously-induced inflammation
104,105. After exposure to rhinovirus or influenza those individuals that became infected
showed increase in IL-6 production that was associated with reduced positive (but not
increased negative) affect 106. The introduction of an endotoxin (Salmonella abortus equi)
and concomitant increases in inflammatory markers was associated with increased
sleepiness 107 and also depressed mood 108. Administration of the Salmonella typhi vaccine
and associated increases in IL-6 resulted in increased negative mood 109. Increases in IL-6
after receiving the influenza vaccine were associated with increases in depressed mood
(though not with decreases in positive affect or increases in fatigue 110. However, few
studies have focused on suicidality using these paradigms and subsequent work might focus
on this.

Author Manuscript

In the present study, IL-8, but not IL-6, showed shared genetic influences with risk for
suicide attempt. This genetic overlap appeared to be particularly pronounced in females,
providing strong evidence for a sex-specific effect whereby the same biologic mechanisms
that drive IL-8 production and metabolism also drive, at least to a certain extent, suicide
attempts in women. Moreover, based on the results of this study, the effect of BMI on
inflammation levels may have confounded results from previous studies that placed greater
emphasis on IL-6 for suicide risk. These findings represents a significant advancement in
knowledge by demonstrating that inflammation alterations are not simply a secondary
manifestation of suicidal behavior, but rather, the pathophysiology of suicide attempts is, at
least partly, underpinned by the same biological mechanisms responsible for regulating
inflammatory response.
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Highlights
•

IL-8 level and risk for suicide attempt are driven by a common set of genes

•

The genetic correlation, derived via multivariate variance components
methods. between IL-8 and suicide attempt was driven by females

•

BMI is an important source of bias in IL-6 levels

•

BMI should be considered when assessing the association between IL-6 and
suicide

•

Pathophysiology of suicide attempts is underpinned by the same biological
mechanisms responsible for regulating inflammatory response
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Figure 1.

Average levels of IL-6 and IL-8 in suicide attempters, unaffected relatives, and unaffected
unrelateds.
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Figure 2.

Trivariate polygenic model of IL-6, BMI and lifetime suicide attempt.
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Descriptive statistics (N, % female, mean age and BMI) of those individuals that have attempted suicide and
those individuals that have current suicidal ideation.
Phenotype

Endorsement

Suicide Attempt

Current Suicidal Ideation

N

% Female

Age
(SD)

BMI
(SD)

Yes

159

70.44

41.09
(13.45)

32.65
(7.72)

No

1725

58.72

42.23
(15.93)

31.57
(7.49)

Yes

135

74.07

42.73
(16.92)

31.42
(7.80)

No

1749

58.60

42.09
(15.65)

31.67
(7.50)
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0.64
(0.42)
70.40
(4.84x10−17)
30.24
(3.82x10−08)
87.94
(6.73x10−21)

2.75x10−04
2.86x10−08
5.46x10−05
4.54x10−14

0.46
(0.16)
0.26
(0.05)
0.17
(0.05)
0.30
(0.05)

TNF-α

IL-6

IL-8

0.61
(0.43)

2.68x10−05

0.47
(0.13)

Suicide Attempt

Suicidal Ideation

age

p

h2
(se)

Trait

4.56
(0.03)

2.32
(0.13)

0.52
(0.47)

0.01
(0.91)

0.74
(0.39)

ag^2

19.07
(1.26x10−05)

2.00
(0.16)

9.39
(2.18x10−03)

4.31
(0.04)

6.33
(0.01)

sex

1.10
(0.29)

1.59
(0.21)

0.50
(0.48)

0.04
(0.85)

0.87
(0.35)

age*sex

5.80
(0.02)

0.19
(0.66)

5.65
(0.02)

0.42
(0.52)

0.42
(0.51)

age^2*sex

1.17
(0.28)

123.55
(1.06x10−28)

27.93
(1.26x10−07)

0.01
(0.93)

1.03
(0.31)

BMI

estimates, p-values and X2 (and p-values) for covariates. Significant covariates are highlighted in bold.

Univariate polygenic analysis results for risk for suicide attempt and current suicidal ideation and inflammatory markers, including h2 (and standard error)
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Bivariate polygenic analysis results each suicide trait (lifetime suicide attempt and current suicidal ideation)
paired with an inflammatory marker (TNF-α, IL-6, IL-8). including ρg (and standard error) estimates and pvalues.
Suicide Trait

Inflammation
Marker

ρg(se)

pFDR

Lifetime Suicide Attempt

TNF-α

0.10 (0.10)

0.60

IL-6

0.37 (0.23)

0.12

IL-8

0.49 (0.17)

8.94x10−03

TNF-α

0.15 (0.20)

0.47

IL-6

0.39 (0.23)

0.15

IL-8

0.29 (0.16)

0.15

Current Suicidal Ideation
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